Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# Ivy Robots file User-agent: * Disallow: /search-results* Disallow: /page-not-found* Disallow: /system-error* Disallow: /jcr* Disallow: /generatepdf* Disallow: /api/* Disallow: /thank-you* Disallow: /cost* # Disallow: /etc/clientlibs* # Disallow: /content/forms/af/* Disallow: /content/usergenerated/content/forms/af/* Disallow: /previously-treated-cll* Sitemap: https://www.venclexta.com/sitemap.xml Sitemap: https://www.venclexta.com/video-sitemap.xml Sitemap: |
Title | VENCLEXTA® (venetoclax tablets): CLL/SLL and AML |
Description | An oral therapy to help you fight certain blood Discover VENCLEXTA® (venetoclax tablets): An oral therapy to help you fight certain blood cancers. See full Prescribing and Safety |
Keywords | AML + CLL Combination |
WebSite | venclexta.com |
Host IP | 159.180.132.176 |
Location | United States |
Site | Rank |
US$68,640,098
Last updated: 2023-05-03 05:23:49
venclexta.com has Semrush global rank of 154,200. venclexta.com has an estimated worth of US$ 68,640,098, based on its estimated Ads revenue. venclexta.com receives approximately 7,920,012 unique visitors each day. Its web server is located in United States, with IP address 159.180.132.176. According to SiteAdvisor, venclexta.com is safe to visit. |
Purchase/Sale Value | US$68,640,098 |
Daily Ads Revenue | US$63,361 |
Monthly Ads Revenue | US$1,900,803 |
Yearly Ads Revenue | US$22,809,633 |
Daily Unique Visitors | 528,001 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
venclexta.com. | A | 300 | IP: 159.180.132.176 |
venclexta.com. | NS | 3600 | NS Record: ns-1224.awsdns-25.org. |
venclexta.com. | NS | 3600 | NS Record: ns-139.awsdns-17.com. |
venclexta.com. | NS | 3600 | NS Record: ns-1808.awsdns-34.co.uk. |
venclexta.com. | NS | 3600 | NS Record: ns-998.awsdns-60.net. |
venclexta.com. | NS | 3600 | NS Record: abvegdmzns1.abbvie.com. |
venclexta.com. | NS | 3600 | NS Record: abvludmzns1.abbvie.com. |
venclexta.com. | NS | 3600 | NS Record: abvsgdmzns1.abbvie.com. |
venclexta.com. | TXT | 3600 | TXT Record: v=spf1 exists:%{i}._i.%{d}._d.espf.dmp.cisco.com include:%{d}.ff.spf-protect.dmp.cisco.com -all |
venclexta.com. | TXT | 3600 | TXT Record: facebook-domain-verification=pcg7yqk47xi83juc1xo9rsfoytarcr |
venclexta.com. | TXT | 3600 | TXT Record: google-site-verification=Ak_HUMIxuhv5NNgCo_QMXF5wH_SJCHZMyX73EeOG5U8 |
Select Condition Previously Untreated CLL Previously Treated CLL AML Medication Guide Prescribing Information Safety Information HEALTHCARE PROFESSIONAL SITE Previously Untreated CLL/SLL Previously Treated CLL/SLL AML HEALTHCARE PROFESSIONAL SITE SAFETY Get VENCLEXTA treatment support: (844) 926-6727 Get VENCLEXTA treatment support: (844) 926-6727 , M–F, 7am–7pm CST An oral therapy to help you fight certain blood cancers Previously Untreated CLL/SLL Previously Treated CLL/SLL Acute Myeloid Leukemia CLL=chronic lymphocytic leukemia; SLL=small lymphocytic lymphoma. Have questions about your treatment with VENCLEXTA? Call our nurse* support line for VENCLEXTA. You can speak with our Registered Nurses* about your treatment with VENCLEXTA—at no cost to you. Call our nurse* support line: Monday–Friday, 7am–7pm CST Call our nurse* support line: (844) 926-6727 Monday–Friday, 7am–7pm CST * The nurses from the nurse support line are provided by AbbVie and do not work under the direction of a |
HTTP/1.0 301 Moved Permanently Location: http://www.venclexta.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/1.1 301 Moved Permanently Server: CloudFront Date: Mon, 25 Oct 2021 12:29:25 GMT Content-Type: text/html Content-Length: 183 Connection: close Location: https://www.venclexta.com/ X-Cache: Redirect from cloudfront Via: 1.1 282ef04eccac8dc852a926793ca496e3.cloudfront.net (CloudFront) X-Amz-Cf-Pop: ORD53-C3 X-Amz-Cf-Id: zzteEkMPz9wlYkcSb8ovEwfT2Zvnwju1yZeeFE0lGJuejj_oyUg0rA== HTTP/2 200 content-type: text/html;charset=utf-8 content-length: 181058 accept-ranges: bytes last-modified: Tue, 19 Oct 2021 22:55:00 GMT server: Apache strict-transport-security: max-age=31536000; includeSubDomains x-content-type-options: nosniff x-dispatcher: dispatcher2useast1 x-frame-options: SAMEORIGIN x-vhost: publish cache-control: max-age=300, public cache-control: no-cache="set-cookie" date: Mon, 25 Oct 2021 12:29:25 GMT etag: "2c342-5cebc8d19b900" x-cache: RefreshHit from cloudfront via: 1.1 fee2e0fc8d516ec2db8a330862bc0b8f.cloudfront.net (CloudFront) x-amz-cf-pop: ORD53-C3 x-amz-cf-id: 0wWBWynjioYrJF4Y0nd5I4_KPkdVUMD8B0Uyj9LQ4gaOcscmIUK7KA== |
Domain Name: VENCLEXTA.COM Registry Domain ID: 1890856549_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-11-15T10:20:16Z Creation Date: 2014-12-17T15:53:52Z Registry Expiry Date: 2021-12-17T15:53:52Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: ABVEGDMZNS1.ABBVIE.COM Name Server: ABVLUDMZNS1.ABBVIE.COM Name Server: ABVSGDMZNS1.ABBVIE.COM Name Server: NS-1224.AWSDNS-25.ORG Name Server: NS-139.AWSDNS-17.COM Name Server: NS-1808.AWSDNS-34.CO.UK Name Server: NS-998.AWSDNS-60.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T15:55:18Z <<< |